Emergent BioSolutions Inc. (EBS) › Total AssetsEmergent BioSolutions Inc. (EBS) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $500.32M2011: $546.86M2012: $564.23M2013: $626.63M2014: $938.69M2015: $1.04B2016: $970.11M2017: $1.07B2018: $2.23B2019: $2.33B2020: $2.88B2021: $2.96B2022: $3.17B2023: $1.82B2024: $1.39B2025: $1.32B$1.32B2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$1.32B-5.1%2024$1.39B-23.8%2023$1.82B-42.4%2022$3.17B+7.1%2021$2.96B+2.6%2020$2.88B+23.9%2019$2.33B+4.4%2018$2.23B+108.3%2017$1.07B+10.3%2016$970.11M-6.5%2015$1.04B+10.5%2014$938.69M+49.8%2013$626.63M+11.1%2012$564.23M+3.2%2011$546.86M+9.3%2010$500.32M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share